Clinical Trial Update: Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for Lomecel-B delivered during stage II surgery in hypoplastic left heart syndrome (HLHS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome

Drugs mentioned

• Lomecel-B (bone marrow-derived mesenchymal stromal cells)

Snippet

Sponsor: Longeveron Inc. | Conditions: HLHS | Phase 1, Phase 2 | Status: UNKNOWN